28.25
-0.25
(-0.88%)
At close: January 22 at 1:30:38 PM GMT+8
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,089,639.00
1,143,073.00
1,022,298.00
979,359.00
Cost of Revenue
718,531.00
720,565.00
665,719.00
656,435.00
Gross Profit
371,108.00
422,508.00
356,579.00
322,924.00
Operating Expense
287,877.00
268,676.00
237,520.00
247,362.00
Operating Income
83,231.00
153,832.00
119,059.00
75,562.00
Net Non Operating Interest Income Expense
9,998.00
-169.00
-676.00
1,571.00
Pretax Income
112,103.00
162,284.00
131,775.00
81,425.00
Tax Provision
-3,482.00
-16,998.00
24,079.00
22,284.00
Net Income Common Stockholders
115,493.00
154,006.00
80,751.00
59,141.00
Diluted NI Available to Com Stockholders
115,493.00
154,006.00
80,751.00
59,141.00
Basic EPS
2.02
2.70
1.42
1.04
Diluted EPS
2.02
2.69
1.41
1.03
Basic Average Shares
56,983.00
56,983.00
56,983.00
56,983.00
Diluted Average Shares
57,261.00
57,315.00
57,279.00
57,221.00
Total Expenses
1,006,408.00
989,241.00
903,239.00
903,797.00
Net Income from Continuing & Discontinued Operation
115,493.00
154,006.00
80,751.00
59,141.00
Normalized Income
115,443.40
179,279.60
107,698.45
59,147.54
Interest Income
11,367.00
1,356.00
417.00
1,733.00
Interest Expense
1,369.00
1,525.00
1,093.00
162.00
Net Interest Income
9,998.00
-169.00
-676.00
1,571.00
EBIT
113,472.00
163,809.00
132,868.00
81,587.00
EBITDA
175,169.00
236,686.00
211,944.00
165,729.00
Reconciled Cost of Revenue
718,531.00
720,565.00
665,719.00
656,435.00
Reconciled Depreciation
61,697.00
72,877.00
79,076.00
84,142.00
Net Income from Continuing Operation Net Minority Interest
115,585.00
179,282.00
107,696.00
59,141.00
Total Unusual Items Excluding Goodwill
177.00
3.00
-3.00
-9.00
Total Unusual Items
177.00
3.00
-3.00
-9.00
Normalized EBITDA
174,992.00
236,683.00
211,947.00
165,738.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
35.40
0.60
-0.55
-2.46
12/31/2020 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1752.TW Nang Kuang Pharmaceutical Co., Ltd.
41.45
+0.36%
4116.TWO BenQ Medical Technology Corporation
45.05
-0.33%
4107.TWO Bioteque Corporation
123.00
-0.40%
4126.TWO Pacific Hospital Supply Co., Ltd
94.60
0.00%
1783.TW Maxigen Biotech Inc.
50.30
-2.90%
5312.TWO Formosa Optical Technology Co.,Ltd.
111.00
+0.45%
6499.TWO Medeon Biodesign, Inc.
37.70
+0.27%
6782.TW Visco Vision Inc.
163.50
+0.93%
4771.TW Vizionfocus Inc.
157.50
-1.56%
1786.TW SciVision Biotech Inc.
123.00
-0.40%